Mutations of ARID1A seem to be frequently involved in ERONs, and almost 73% of heterozygous mutated ovarian tumors are characterized by a loss of protein expression without the loss of heterozygosity [40]. The gene discussed is ARID1A; the disease is ovarian neoplasm.